SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000320017-23-000031
Filing Date
2023-06-14
Accepted
2023-06-14 17:05:38
Documents
12
Period of Report
2023-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K clbs-20230614.htm   iXBRL 8-K 33041
  Complete submission text file 0000320017-23-000031.txt   172923

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clbs-20230614.xsd EX-101.SCH 1895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clbs-20230614_lab.xml EX-101.LAB 25156
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clbs-20230614_pre.xml EX-101.PRE 13042
6 EXTRACTED XBRL INSTANCE DOCUMENT clbs-20230614_htm.xml XML 11073
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 231014918
SIC: 8090 Services-Misc Health & Allied Services, NEC